JUL 29, 2020 5:00 PM EDT

Enabling 3D T-Cell, Tumoroid Invasion, and Organoid Assays Through the Incorporation of Live Cellular Imaging

C.E. Credits: Florida CE P.A.C.E. CE
Speaker

Abstract

Over the last decade the cancer research field has seen a number of advances aimed at increasing the efficacy of treatments, reducing toxic side effects, and decreasing attrition rates of drug candidates. The first is the rise of immunotherapies which incorporate a patient’s own immune system to combat the cancer. In particular, adoptive immunotherapy techniques activate a patient’s T cells ex vivo against specific tumor antigens before infusing the activated T cells back into the patient to target and destroy tumor cells selectively. A second focus has been the incorporation of three dimensional (3D) in vitro testing models. Traditional use of 2D models many times led to attrition rates of drug candidates for cancer reaching 95%, stemming from in vitro drug efficacy values that did not translate to the clinic, as well as unforeseen toxicity issues. 3D models, by comparison, better mimic in vivo conditions found within the target patient, including oxygen and nutrient gradients, increased cell-to-cell and cell-to-ECM interactions, and non-uniform exposure of cells within a 3D structure to the test molecule. In this webinar, the attendee will learn how commonly performed in vitro cancer research procedures can be performed using advanced digital widefield microscopy.

Three areas of focus will be covered:

1. Monitoring directed T cell activation and cell mediated cytotoxicity using co-cultured T cells and 3D target cancer cell models

2. 3D tumoroid invasion within a hydrogel

3. Use of stem cell derived small intestinal organoids for toxicity assessment

Proper label-free and fluorescence image capture techniques will be demonstrated, including the use of z-stacking and montaging to accurately visualize the 3D structures. Image and cellular analysis methods will also be shown to quantify metrics such as stem cell organoid budding, extent of tumoroid invasion, and T cell activation and induced target cell cytotoxicity.


Show Resources
You May Also Like
MAY 11, 2021 10:00 AM PDT
C.E. CREDITS
MAY 11, 2021 10:00 AM PDT
Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
SEP 17, 2021 12:00 PM CST
C.E. CREDITS
SEP 17, 2021 12:00 PM CST
Date: September 16, 2021 Time: 9:00pm (PDT), 12:00am (EDT) 3D cellular models like organoids and spheroids offer an opportunity to better understand complex biology in a physiologically rele...
SEP 29, 2021 11:00 AM PDT
C.E. CREDITS
SEP 29, 2021 11:00 AM PDT
Date: Septembr 29, 2021 Time: 11:00am (PDT), 2:00pm (EDT) 3D cell models are becoming increasingly popular for studying complex biological effects, tissue functionality, and diseases. While...
JUN 09, 2021 7:00 AM PDT
C.E. CREDITS
JUN 09, 2021 7:00 AM PDT
Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
OCT 12, 2021 9:00 AM PDT
C.E. CREDITS
OCT 12, 2021 9:00 AM PDT
Date: October 12, 2021 Time: 9:00am (PDT), 12:00pm (EDT) SCIEX’s next-generation Biologics Explorer software is an innovative platform for the comprehensive and deep characterization o...
Loading Comments...
Show Resources